PL450653A1 - Nowa pochodna ksantonu do zastosowania w leczeniu lub profilaktyce chorób sercowo-naczyniowych - Google Patents
Nowa pochodna ksantonu do zastosowania w leczeniu lub profilaktyce chorób sercowo-naczyniowychInfo
- Publication number
- PL450653A1 PL450653A1 PL450653A PL45065324A PL450653A1 PL 450653 A1 PL450653 A1 PL 450653A1 PL 450653 A PL450653 A PL 450653A PL 45065324 A PL45065324 A PL 45065324A PL 450653 A1 PL450653 A1 PL 450653A1
- Authority
- PL
- Poland
- Prior art keywords
- prevention
- treatment
- cardiovascular diseases
- xanthone derivative
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ujawniono nową pochodną ksantonu do stosowania w leczeniu lub profilaktyce chorób sercowo-naczyniowych, zwłaszcza u osób cierpiących jednocześnie na cukrzycę.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL450653A PL450653A1 (pl) | 2024-12-20 | 2024-12-20 | Nowa pochodna ksantonu do zastosowania w leczeniu lub profilaktyce chorób sercowo-naczyniowych |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL450653A PL450653A1 (pl) | 2024-12-20 | 2024-12-20 | Nowa pochodna ksantonu do zastosowania w leczeniu lub profilaktyce chorób sercowo-naczyniowych |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL450653A1 true PL450653A1 (pl) | 2026-06-22 |
Family
ID=100212306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL450653A PL450653A1 (pl) | 2024-12-20 | 2024-12-20 | Nowa pochodna ksantonu do zastosowania w leczeniu lub profilaktyce chorób sercowo-naczyniowych |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL450653A1 (pl) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL319555A1 (en) * | 1997-04-18 | 1998-10-26 | Univ Jagiellonski Collegium Me | (±)-4-[1-aminosubstituted) derivatives of 2-(hydroxy)-propoxy]-xantone and (±)-6-[1-aminosubstituted) derivatives of 2-(hydroxy)-propoxy]-methylxantone |
| PL363979A1 (pl) * | 2003-12-10 | 2005-06-13 | Uniwersytet Jagielloński Collegium Medicum | Kwasy [2-lub 4-(metylo)-6-ksantonyloksy]-alkanowei ich pochodne |
| PL433619A1 (pl) * | 2020-04-22 | 2021-10-25 | Uniwersytet Jagielloński | Pochodne ksantonu, koncentrat kompozycji promieniochronnej, sposób otrzymywania koncentratu kompozycji promieniochronnej, zastosowanie koncentratu kompozycji promieniochronnej i kosmetyczny produkt promieniochronny |
-
2024
- 2024-12-20 PL PL450653A patent/PL450653A1/pl unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL319555A1 (en) * | 1997-04-18 | 1998-10-26 | Univ Jagiellonski Collegium Me | (±)-4-[1-aminosubstituted) derivatives of 2-(hydroxy)-propoxy]-xantone and (±)-6-[1-aminosubstituted) derivatives of 2-(hydroxy)-propoxy]-methylxantone |
| PL363979A1 (pl) * | 2003-12-10 | 2005-06-13 | Uniwersytet Jagielloński Collegium Medicum | Kwasy [2-lub 4-(metylo)-6-ksantonyloksy]-alkanowei ich pochodne |
| PL433619A1 (pl) * | 2020-04-22 | 2021-10-25 | Uniwersytet Jagielloński | Pochodne ksantonu, koncentrat kompozycji promieniochronnej, sposób otrzymywania koncentratu kompozycji promieniochronnej, zastosowanie koncentratu kompozycji promieniochronnej i kosmetyczny produkt promieniochronny |